The company offers biopharmaceutical products focused on rare diseases, including the treatment of oral mucositis, a common and debilitating side-effect of radiotherapy and high dose chemotherapy. EUSA Pharma has a wide distribution network of commercial partners in Europe, the Middle East, Asia, and Latin America and makes products available in approximately 40 countries across the world through this broad international platform.